Home » Topics » BioWorld Science

BioWorld Science
RSS

Results on sodium oxybate presented in pediatric patients with narcolepsy type 1

April 25, 2018

Third Rock Ventures launches Cedilla Therapeutics

April 25, 2018

Completion of phase I study of tozuleristide in pediatric brain tumor surgery

April 25, 2018

Nektar, Takeda to evaluate NKTR-214 in combination with TAK-659

April 25, 2018

Initiation of phase Ib trial of CMP-001 plus atezolizumab in anti-PD-1/PD-L1 resistant NSCLC

April 25, 2018

Procalcitonin predicts malignant cerebral edema after massive cerebral infarction

April 25, 2018

U.S. Navy describes novel anti-CD20 antibodies

April 25, 2018

Afecta Pharmaceuticals patents novel hgh mobility group protein B1 inhibitors

April 25, 2018

Galapagos initiates clinical trial with triple combination therapy in cystic fibrosis

April 25, 2018

Novartis offers overview of first quarter 2018

April 25, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...